Prolonged release formulation of carbamazepine

Details Prolonged release formulation of carbamazepine Prolonged release formulation of carbamazepine

A - Human Necessities

61

K

A61K 31/55 (2006.01) A61K 9/22 (2006.01) A61P 25/08 (2006.01) A61K 47/32 (2006.01)

Patent

CA 2303973

The present invention provides a pharmaceutical preparation in tablet form, where the active ingredient is an anti-epileptic medication, preferably a sustained release formulation, and most preferably a sustained release formulation where the active ingredient is carbamazepine. The product consists of carbamazepine particles coated with a single hydrophobic layer and is in a disintegrating tablet form.

La présente invention prévoit une préparation pharmaceutique sous forme de comprimés, où l'ingrédient actif est un médicament antiépileptique, de préférence une formulation à libération prolongée, et de préférence une formulation à libération prolongée, où l'ingrédient actif est la carbamazépine. Le produit est constitué de particules de carbamazépine recouvertes d'une unique couche hydrophobe et est présenté sous forme de comprimé qui se désagrège.

Affiliated with

Also associated with

Rating

Prolonged release formulation of carbamazepine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prolonged release formulation of carbamazepine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolonged release formulation of carbamazepine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1472238